CID 16063245

Radotinib

Structural Information

Molecular Formula
C27H21F3N8O
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=NC=CN=C5
InChI
InChI=1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37)
InChIKey
DUPWHXBITIZIKZ-UHFFFAOYSA-N
Compound name
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

36
References

4242
Patents

530.179 Da
Monoisotopic Mass

3.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 531.18628 216.2
[M+Na]+ 553.16822 228.2
[M+NH4]+ 548.21282 217.7
[M+K]+ 569.14216 224.3
[M-H]- 529.17172 218.6
[M+Na-2H]- 551.15367 225.6
[M]+ 530.17845 218.2
[M]- 530.17955 218.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe